Contact
Please use this form to send email to PR contact of this press release:
Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
TO:
Please use this form to send email to PR contact of this press release:
Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
TO: